View Cart  

Artificial Pancreas Guidance Retains Flexibility, Focus on Human Factors

Companies developing artificial pancreas device systems for type 1 diabetes should demonstrate that the device is safe for layperson use and address such real-world concerns as mobility and water exposure, an FDA final guidance says.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00